Drugs / ALZ-1101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01896180 | Jul 2013 → Jan 2014 | ocular hypertension, open-angle glaucoma | Alleanza Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALZ-1101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01896180 ↗ |
| Route | Topical | “via topical ocular adminstration” NCT01896180 ↗ |